Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 26, 2007

View Archived Issues

Studies of dapagliflozin, sergliflozin presented at EASD

Phase I/II studies assess ABT-751 combination therapy in non-small cell lung cancer

CADI-05 enhances chemotherapy for non-small cell lung cancer

Preclinical antitumor activity of the HDAC inhibitor panobinostat

Collaboration between SMA Foundation and BG Medicine / News in Context

CHMP recommends approval of Tasigna in CML patients nonresponsive to Glivec

NIDDK plans study of diabetes vaccine Diamyd for type 1 diabetes

FDA approves Novo Nordisk's Norditropin for children with Turner syndrome

Roche places hold on development of MAXY-alpha for hepatitis C and B

Exelixis and Bristol-Myers extend collaboration agreement for therapies targeting LXR

Patient enrollment for NeurogesX's confirmatory phase III trial of NGX-4010 completed

Efficacy of RAM-150 against multidrug-resistant pathogens

Pan-PPAR agonist PPM-204 lowers glucose and insulin in patients with type 2 diabetes

Novozymes reports on new defensin-type plectasin derivatives with in vivo antibacterial efficacy

CHMP issues positive opinion for Pegintron and Rebetol for retreating hepatitis C

Abbott and Eisai file for approval of second indication of adalimumab in Japan

Odanacatib increases bone mineral density in postmenopausal women

Preclinical models, phase I study detail activity of ACE-011

Eucreas recommended for E.U. approval in type 2 diabetes

Onconase enhances radiation responses in models of lung cancer

Adnexus Therapeutics to be acquired by Bristol-Myers Squibb

CHMP grants positive opinion to Vectibix MAA for metastatic colorectal cancer

Metabolex initiates phase II trial of MBX-8025 alone and with Lipitor

New therapeutic agents for heart failure disclosed in recent Cytokinetics patent

Novel agents for treating irritable bowel syndrome disclosed in recent Astellas patents

Novel treatment option for obesity and related disorders reported in recent Glenmark patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...